Live Sessions: Thinking Big with Maria Soloveychik
Maria Soloveychik is CEO and co-founder of SyntheX Inc. which aims to create and design new synthetic drugs to cure treatment-resistant types of cancer. Using a special screening platform that helps identify the exact needs of each patient, Maria develops specific drugs to address these otherwise untreatable conditions. SyntheX Inc. also develops cutting edge treatments for other conditions such as rare congenital disorders, neurodegeneration, psychiatric disorders and for various infections. Soloveychik graduated from the University of Toronto where she obtained her HBSc degree in Molecular Genetics and Microbiology and also received her doctoral training in epigenetics and cancer metabolomics.
Frequently Asked Questions
When does the course start and finish?
The course starts now and never ends! It is a completely self-paced online course - you decide when you start and when you finish.
How long do I have access to the course?
How does lifetime access sound? After enrolling, you have unlimited access to this course for as long as you like - across any and all devices you own.
What if I am unhappy with the course?
We would never want you to be unhappy! If you are unsatisfied with your purchase, contact us in the first 30 days and we will give you a full refund.